Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-01-31 @ 5:04 AM
Study NCT ID:
NCT05510895
Status:
COMPLETED
Last Update Posted:
2025-10-01
First Post:
2022-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer
Sponsor:
AIO-Studien-gGmbH
Organization: